88IV - PR Newswire Asia's news


Kelun-Biotech Announces Three Clinical Study Results Selected for Oral Presentations at 2026 ASCO Annual Meeting CHENGDU, China , April 22, 2026 /PRNewswire/ -- The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago from May 29 to June 2. In this meeting, Sichuan Kelun-Biotech ... 2026-04-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Case Report of Mabwell's Nectin-4 targeting ADC (9MW2821) in Cervical Cancer Published in The New England Journal of Medicine SHANGHAI , April 22, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industrial chain, announced that a recent clinical case report on ... 2026-04-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ViGenCell's VT-EBV-N Selected for Oral Presentation at ASCO 2026 Phase 2 study of EBV-specific T cell therapy to be presented at a leading oncology meeting ... 2026-04-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ReviR Therapeutics Receives Strategic Investment from CureCMT to Advance a First-of-its-Kind Precision Medicine Platform for CMT An isogenic iPSC and AI-enabled disease modeling platform spanning multiple genetically defined CMT subtypes will be established to support patient stratification, accelerate RTX-117 development, and create ... 2026-04-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Insilico Medicine Announces Industry's First Longevity Board to Accelerate AI-Driven Aging Research for Drug Discovery CAMBRIDGE, Mass. , April 21, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced ... 2026-04-21T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
HKeybio Launches World's First NHP Hidradenitis Suppurativa Model with High Clinical Consistency to Tackle Global Drug R&D Bottleneck BOSTON and SUZHOU, China , April 21, 2026 /PRNewswire/ -- HKeybio Tech., a global leader in non-human primate (NHP) experimental animal model research and development, today announced the official ... 2026-04-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Celltrion to present seven abstracts in inflammatory bowel disease (IBD) at 2026 Digestive Disease Week® (DDW) Seven abstracts accepted for presentation include data from long-term follow-up studies and a post-hoc analysis of the pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC) of ZYMFENTRA ® (infliximab-dyyb) ... 2026-04-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program Five-year collaboration supports consistent clinical supply for Phase 1A/1B GI cancer study ... 2026-04-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
From Molecular Design to Scalable Execution: The Combined Impact of AI and Flow Chemistry SHANGHAI , April 21, 2026 /PRNewswire/ -- As drug discovery places greater emphasis on practical execution and scalable delivery, flow chemistry is playing an increasingly important role across modern ... 2026-04-21T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Cadonilimab Combination Demonstrates Promising Survival Benefit in Locally Advanced Pancreatic Cancer: Phase II COMPASSION-26 Data Presented at AACR 2026 HONG KONG , April 21, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that positive Phase II results from the COMPASSION-26 study evaluating cadonilimab, ... 2026-04-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology